Consumer Cyclical
Live Price
Offline$2.62
-0.38% today
1Y Change
+2.57%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Petco Health and Wellness Company, Inc. (WOOF) is a Consumer Cyclical stock with a market cap of $790.00M and listed on NASDAQ. The stock last traded around $2.62 and up 2.6% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -2.5%, EPS growth of +108.8%, a dividend yield of 0.0%. What stands out right now is revenue -2.5%, EPS +108.8%, free cash flow +276.3% with operating margin 2.0% and ROIC 2.4%. Valuation already assumes a fairly strong business story at P/E 86.2 and price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WOOF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WOOF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WOOF Max Drawdown
-46.56%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WOOF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$5.8B
-3.8% YoY
FY Net Income
$164.4M
+81.1% YoY
Free Cash Flow
$119.1M
+75.2% YoY
Revenue Growth
-2.5%
EPS Growth
+108.8%
Gross Margin
38.7%
Net Margin
0.2%
Income statement
USD
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 6.0B | 6.1B | 6.3B | 6.0B | 5.8B |
| Gross Profit | 2.3B | 2.3B | 2.4B | 2.4B | 2.4B |
| Operating Income | 120M | 7M | -1.2B | 226M | 266M |
| EBITDA | 317M | 7M | -972M | 408M | 452M |
| Net Income | 9M | -102M | -1.3B | 91M | 164M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | 257M | 166M | 125M | 202M | 212M |
| Total Assets | 5.2B | 5.2B | 5.4B | 6.6B | 6.5B |
| Total Liabilities | 4.0B | 4.1B | 4.2B | 4.2B | 4.2B |
| Shareholder Equity | 1.2B | 1.1B | 1.2B | 2.4B | 2.3B |
| Total Debt | 2.9B | 3.0B | 3.0B | 3.1B | 3.0B |
| Net Debt | 2.6B | 2.8B | 2.9B | 2.9B | 2.8B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
358M
+3.5% YoY
Capital Expenditures
239M
+14.0% YoY
Free Cash Flow
119M
+75.2% YoY
Key ratios
Gross Margin
38.7%
Operating Margin
2.0%
Net Margin
0.2%
ROE
0.8%
Debt / Equity
2.46x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.